A thread ONLY aimed to present PREVIOUS information on PREVIOUS outbreaks. History sometimes repeats itself, so do persons/institutions/procedures. Any analysis based on reappearance of similar institutions/procedures/persons should take difference in time/tech into consideration

#MERS The 2012-2013 also had similarities, the first beta coronavirus outbreak after 2003 #SARS, person in charge was the same compared with #COVID19.
So, let's roll.

#MERS 20131015 presentation by Wenjie Tan of China CDC, on pathogenicity and detection. 1/12

#MERS 2/12

#MERS 3/12

ILI, UP daily reports
2019-09-13

ILI, UP daily reports
2019-09-14

ILI, UP daily reports
2019-09-15

ILI, UP daily reports
2019-09-16

ILI, UP daily reports
2019-09-17

This thread is #Genbank records regarding #MN908947. Evidence only, any further analysis upon this record subjects to individuals' own discretion. So, let's roll.

1/n

2/n

3/n

4/n

#CHINACDC #IVDC #BSL3 #BSL4
Biosafety
Wu Guizhen
2019 May
1/15

Biosafety
Wu Guizhen
2019 May
2/15

Biosafety
Wu Guizhen
2019 May
3/15

Biosafety
Wu Guizhen
2019 May
4/15

Biosafety
Wu Guizhen
2019 May
5/15

Health surveillance risk assessment daily reports, Mojiang, Yunnan, unknown pneumonia cases.
2012-12-04 part 1

Health surveillance risk assessment daily reports, Mojiang, Yunnan, unknown pneumonia cases.
2012-12-04 part 2

Health surveillance risk assessment daily reports, Mojiang, Yunnan, unknown pneumonia cases.
2012-12-04 part 3

Original medical records of GD pangolin
1/n
CT scans & diagnosis

Original medical records of GD pangolin
2/n
Blood tests(MEIDONG) in 2019

Original medical records of GD pangolin
3/n
Blood tests(MEIDONG) in 2019

Original medical records of GD pangolin
4/n
Blood tests in 2019

Original medical records of GD pangolin
5/n
Blood tests in 2019

Draft of Chaoyang District cluster cases + peer review comment
1/n

Draft of Chaoyang District cluster cases + peer review comment
2/n

Draft of Chaoyang District cluster cases + peer review comment
3/n

Draft of Chaoyang District cluster cases + peer review comment
4/n

Draft of Chaoyang District cluster cases + peer review comment
5/n

#SARSCOV2 #origin This thread is about analysis of origin search of SARS-COV-2 in various outbreaks in China. The 'origin search' is more for epi purpose, not quite similar as the 'origin research' in viral evolution. Of course, first cases and Huanan market include here.
1/n

#SARSCOV2 #origin First, let's have some taste of the mutation analysis of full genome sequencing with some covid-19 patients in Wuhan, by #IVDC
2/n

#SARSCOV2 #origin Then, the set up of task force to assess the food safety risk of potential transmission via cold chain.
3/n

#SARSCOV2 #origin
Initial results of the first batch of samples from Wuhan on 2nd January 2020. After Visionmedicals & BGI got their preliminary results ID as SARSr-CoV. 4/n

#SARSCOV2
4 samples received around GMT+8 12:30, pan-beta-COV(RdRp) qPCR performed, Ct value around 34. Common respiratory pathogens screening via qPCR in parallel, started viral inoculation in three cell lines, Vero E6, Huh-7, human respiratory epithelial cells.

#CNIC #ZHAOXIANG #XINLIHECHUANG
Thread about Zhaoxiang et al, team of China national influenza center, one of the authors of first SARSCOV2 genomes in GISAID, evidence of funnelling money into one of his/theirs private company Xinlihechuang(Beijing).1/n

#CNIC #ZHAOXIANG #XINLIHECHUANG
Zhaoxiang's bio
2/n

#CNIC #ZHAOXIANG #XINLIHECHUANG
Wangdayan's bio
3/n

#CNIC #ZHAOXIANG #XINLIHECHUANG
Xinlihechuang(Beijing)'s product manual in 2013
4/n

#CNIC #ZHAOXIANG #XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019
5/n

Health surveillance risk assessment daily reports
2019-8-19 part 1

Health surveillance risk assessment daily reports
2019-8-19 part 2

Health surveillance risk assessment daily reports
2019-8-20 part 1

Health surveillance risk assessment daily reports
2019-8-20 part 2

Health surveillance risk assessment daily reports
2019-8-22 part 1